259 related articles for article (PubMed ID: 9086574)
1. Methimazole-induced severe aplastic anemia: unsuccessful treatment with recombinant human granulocyte-monocyte colony-stimulating factor.
Escobar-Morreale HF; Bravo P; García-Robles R; García-Laraña J; de la Calle H; Sancho JM
Thyroid; 1997 Feb; 7(1):67-70. PubMed ID: 9086574
[TBL] [Abstract][Full Text] [Related]
2. Methimazole-induced aplastic anemia in third exposure: successful treatment with recombinant human granulocyte colony-stimulating factor.
Mezquita P; Luna V; Muñoz-Torres M; Torres-Vela E; Lopez-Rodriguez F; Callejas JL; Escobar-Jimenez F
Thyroid; 1998 Sep; 8(9):791-4. PubMed ID: 9777751
[TBL] [Abstract][Full Text] [Related]
3. Treatment of methimazole-induced severe aplastic anemia with recombinant human granulocyte-monocyte colony-stimulating factor and glucocorticosteroids.
López-Karpovitch X; Ulloa-Aguirre A; von Eiff C; Hurtado-Monroy R; Alanis A
Acta Haematol; 1992; 87(3):148-50. PubMed ID: 1642096
[TBL] [Abstract][Full Text] [Related]
4. Methimazole-induced aplastic anemia caused by hypocellular bone marrow with plasmacytosis.
Yamamoto A; Katayama Y; Tomiyama K; Hosoai H; Hirata F; Kimura F; Fujita K; Yasuda H
Thyroid; 2004 Mar; 14(3):231-5. PubMed ID: 15072706
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of methimazole-induced severe aplastic anemia with recombinant human granulocyte colony-stimulating factor and high-dosage steroids.
Jakucs J; Pocsay G
J Endocrinol Invest; 2006 Jan; 29(1):74-7. PubMed ID: 16553037
[TBL] [Abstract][Full Text] [Related]
6. [Immunosuppressive therapy for aplastic anemia--review].
Xu CY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Apr; 13(2):348-52. PubMed ID: 15854308
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics of antithyroid drug-induced aplastic anemia cases over the past 30 years.
Cheng Y; Xia XY; Zhang W; Ren L; Tian CF; Liu D; Xue G
Front Endocrinol (Lausanne); 2023; 14():1064723. PubMed ID: 36777352
[TBL] [Abstract][Full Text] [Related]
8. Transient methimazole-induced bone marrow aplasia: in vitro evidence for a humoral mechanism of bone marrow suppression.
Moreb J; Shemesh O; Shilo S; Manor C; Hershko C
Acta Haematol; 1983; 69(2):127-31. PubMed ID: 6188311
[TBL] [Abstract][Full Text] [Related]
9. Antithyroid drug-induced agranulocytosis: clinical experience with ten patients treated at one institution and review of the literature.
Meyer-Gessner M; Benker G; Lederbogen S; Olbricht T; Reinwein D
J Endocrinol Invest; 1994 Jan; 17(1):29-36. PubMed ID: 7516356
[TBL] [Abstract][Full Text] [Related]
10. Bone remodelling after growth factor and cyclosporine A therapy for aplastic anemia.
Derfus BA; Csuka ME; Carrera GF; Hanson GA; Smith RE
J Rheumatol; 1991 May; 18(5):738-42. PubMed ID: 1865422
[TBL] [Abstract][Full Text] [Related]
11. [Progress in biology and therapy of aplastic anemia and other conditions of bone marrow failure].
Robak T
Postepy Hig Med Dosw; 1992; 46(1):21-51. PubMed ID: 1641375
[TBL] [Abstract][Full Text] [Related]
12. [Severe aplastic anemia as a complication of treatment with metizol].
Swider G; Grzywa M; Zuzak Z
Wiad Lek; 1996; 49(7-12):136-9. PubMed ID: 9245107
[TBL] [Abstract][Full Text] [Related]
13. Mesalazine-associated severe aplastic anemia successfully treated with antithymocyte globulin, cyclosporine and granulocyte colony-stimulating factor.
Otsubo H; Kaito K; Sekita T; Shimada T; Kobayashi M; Hosoya T
Int J Hematol; 1998 Dec; 68(4):445-8. PubMed ID: 9885444
[TBL] [Abstract][Full Text] [Related]
14. Treatment of drug-induced bone marrow suppression with recombinant human granulocyte/monocyte colony stimulating factor.
Somogyi A; Rosta A; Lang I; Werling K
Adverse Drug React Toxicol Rev; 1996 Jun; 15(2):119-24. PubMed ID: 8836317
[TBL] [Abstract][Full Text] [Related]
15. Methimazole-induced agranulocytosis treated with recombinant human granulocyte colony-stimulating factor (rhG-CSF): a case report.
Chien MN; Wang CH; Tsan KW
Zhonghua Yi Xue Za Zhi (Taipei); 1995 Nov; 56(5):351-5. PubMed ID: 8605651
[TBL] [Abstract][Full Text] [Related]
16. [Methimazole-induced aplastic anemia].
Mechelli S; Bolognesi S; Siuti E; Stefanelli A; Castiglioni MG
Recenti Prog Med; 1999 Sep; 90(9):470-2. PubMed ID: 10544668
[TBL] [Abstract][Full Text] [Related]
17. Treatment of severe aplastic anemia with antilymphocyte globulin, cyclosporine and two different granulocyte colony-stimulating factor regimens: a GITMO prospective randomized study.
Locasciulli A; Bruno B; Rambaldi A; Saracco P; Dufour C; Finelli C; Sica S; Varotto S; Arcese W; Locatelli F; Soligo D; Bacigalupo A;
Haematologica; 2004 Sep; 89(9):1054-61. PubMed ID: 15377466
[TBL] [Abstract][Full Text] [Related]
18. In vitro effect of stem cell factor on colony growth from acquired severe aplastic anemia.
Bacigalupo A; Piaggio G; Podestá M; Raffo MR; Tedone E; Sogno G; Benvenuto F; Figari O; Grassia L; Bagnara GP
Stem Cells; 1993 Jul; 11 Suppl 2():175-9. PubMed ID: 7691324
[TBL] [Abstract][Full Text] [Related]
19. Haematological improvement by long-term administration of recombinant human granulocyte-colony stimulating factor and recombinant human erythropoietin in a patient with severe aplastic anaemia.
Nawata J; Toyoda Y; Nisihira H; Honda K; Kigasawa H; Nagao T
Eur J Pediatr; 1994 May; 153(5):325-7. PubMed ID: 7518392
[TBL] [Abstract][Full Text] [Related]
20. In vivo recruitment of GM-CSF-response myelopoietic progenitor cells by interleukin-3 in aplastic anemia.
Herrmann F; Lindemann A; Raghavachar A; Heimpel H; Mertelsmann R
Leukemia; 1990 Oct; 4(10):671-2. PubMed ID: 2214870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
